0
Original Investigation |

The Efficacy of Unilateral Bone-Anchored Hearing Devices in Chinese Mandarin-Speaking Patients With Bilateral Aural Atresia ONLINE FIRST

Yue Fan, MD1; Ying Zhang, MD1; Pu Wang, MD1; Zhen Wang, MD1; Xiaoli Zhu, MD1; Hua Yang, MD1; Xiaowei Chen, MD1
[+] Author Affiliations
1Department of Otolaryngology, Peking Union Medical College Hospital, Beijing, China
JAMA Otolaryngol Head Neck Surg. Published online February 06, 2014. doi:10.1001/jamaoto.2013.6642
Text Size: A A A
Published online

Importance  The bone-anchored hearing device (BAHD) was not introduced in China until 2010. To our knowledge, this is the first study to assess the efficacy of Chinese Mandarin-speaking patients with bilateral aural atresia.

Objective  To evaluate the speech recognition of Chinese Mandarin-speaking patients with BAHDs as well as patients’ satisfaction using 2 questionnaires.

Design, Setting, and Participants  A retrospective case review of 16 patients with bilateral aural atresia conducted at a tertiary referral center.

Intervention  A BAHD was implanted during auricle reconstruction surgery or after the auricle was rebuilt. A surgical method to combine the BAHD implantation with the second stage of ear reconstruction was introduced.

Main Outcomes and Measures  Speech audiometry test and mean pure-tone threshold results were compared among patients with unaided hearing and those with BAHDs. Scores from the BAHD user questionnaire and Glasgow Children’s Benefit Inventory (GCBI) were used to measure patients’ satisfaction and subjective health benefit.

Results  The mean (SD) speech discrimination scores measured in a sound field with a presentation level of 45 dB HL (hearing level) were 6.7% (7.4%) unaided and 86.5% (4.4%) with a BAHD. Scores with a presentation level of 65 dB HL were 56.5% (7.4%) unaided and 90.1% (3.4%) with a BAHD. The speech reception threshold was 60.6 (7.5) dB HL unaided and 24.7 (5.0) dB HL with a BAHD. The mean (SD) pure-tone threshold of the patients was 61.6 (7.8) dB HL unaided and 23.8 (5.9) dB HL with a BAHD. The BAHD application questionnaire demonstrated excellent patient satisfaction. The mean (SD) benefit score of GCBI was 45.6 (14.4).

Conclusions and Relevance  For aural atresia, the BAHD has been one of the most reliable methods of auditory rehabilitation. It can improve the patient’s word recognition performance and quality of life. The technique of BAHD implantation combined with auricular reconstruction in a 2-stages-in-1 surgery and the modified incision of patients with reconstructed auricle proved to be safe and effective.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Place holder to copy figure label and caption
Figure 1.
Mean Speech Discrimination Scores (SDSs) of 16 Patients With Unaided Hearing and With a BAHD, With Presentation Levels of 45 dB HL and 65 dB HL

Mean (SD) SDSs were 6.7% (7.4%) unaided and 86.5% (4.4%) with a BAHD measured in a sound field of 45 dB HL and 56.5% (7.4%) unaided and 90.1% (3.4%) with a BAHD measured in a sound field of 65 dB HL. BAHD indicates bone-anchored hearing device; and HL, hearing level.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Mean Hearing Thresholds at 500, 1000, 2000, and 4000 Hz for All 16 Patients With and Without BAHDs

Mean (SD) pure-tone thresholds of the patients were 61.6 (7.8) dB HL unaided and 23.8 (5.9) dB HL with a BAHD. The longer horizontal lines indicate the mean speech discrimination score. The 2 shorter horizontal lines indicate the standard deviation. BAHD indicates bone-anchored hearing device; and HL, hearing level.

Graphic Jump Location

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();